Nanobiotix - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NBTX

Tandha merek Nanobiotix SA (NBTX)

The prospects for the global partnership of Nanobiotix S.A. (NBTX) are still crystallizing, which is driving the price action. The French innovator maintains high scientific standing due to its radiotherapy enhancement methods, while drug production is fully outsourced to third-party contractors. The EBITDA_Co metric reflects phases of cash flow consolidation, where 0.00 indicates the current level of operating profit before taxes.

NBTX: Bathi sadurunge mbayar bunga, pajak, lan amortisasi Nanobiotix Group 23.11.2025 - 14.11.2026

Nanobiotix - rincian analitis lan metrik utama (NBTX)

- nilai pasar lan prakiraan target analis:
Rega bursa Nanobiotix|NBTX - Target konsensus
- rincian nilai pasar emiten:
Nilai pasar Nanobiotix SA|NBTX - Nilai Total Perusahaan
- informasi kapitalisasi buku:
Nilai Buku Saham Nanobiotix|NBTX - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku nanobiotix.com|NBTX - Total Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Nanobiotix S.A.|NBTX - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Nanobiotix Corp|NBTX - Gunggung utang perusahaan|Rasio utang-utang marang kapitalisasi buku Nanobiotix SA|NBTX - Utang jangka dawa perusahaan|Utang jangka cendhak Nanobiotix|Rasio jangkoan perantara nanobiotix.com
- informasi bathi lan kelipatan valuasi:
NBTX - Bathi resik perusahaan|Bathi mangsa ngarep Nanobiotix S.A.|NBTX - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi Nanobiotix SA|NBTX - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Nanobiotix S.A.|NBTX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Nanobiotix|NBTX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan nanobiotix.com|NBTX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Nanobiotix S.A.
- data dodolan lan asil:
NBTX - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan Nanobiotix S.A.|NBTX - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Nanobiotix SA
Ringkesan analitik perusahaan:nanobiotix.com, NBTX
Produk asli nanobiotix.com

Nanobiotix S.A. (NBTX) is developing advanced nanopharmaceuticals for radiotherapy, aiming for monetization through partnerships. The current EBITDA metric, equal to 0.00, mathematically aggregates daily cash flows from core operations. This indicator measures the actual daily volume of operating profit, excluding non-cash charges. Such monitoring is critical for detecting early signs of business degradation between quarterly reports. Analysis of this chart allows investors to timely assess the company's stability during clinical trials.

Pesaing Nanobiotix S.A. (NBTX)

Geron (GERN) - Bathi sadurunge bunga, pajak, lan amortisasi|BCYC: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CTMX (CytomX Pharma)|Perspective Therapeutics, Inc. (CATX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi GNLX (Genelux Corp)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Molecular Partners|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ONCY|Bathi operasional EBITDA LSTA|Bathi operasional EBITDA Moleculin (MBRX)|Galera Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MTEM (Molecular Templates Corp)